Doc,

Been a while since I have read and posted on this board; but in response to your question, IMO the share price will respond to news on the head-to-head study being conducted on the POA analyzer, results of Mercks canary study on the paramagnetic beads and (hopefully) full provision of the PIPE executed to capture the funds necessary to operate the company and conduct the remaining development work on the the POC analyzer.

I think the pending 10k will shed some light on each of these issues; but what I really want the company to do is issue Press Releases that announce the relevant results and/or information on each of these items. The fact that CGNH has not issued a Press Release on either of the studies is troubling but I remain optimistic. Having worked in start-up companies I know that trials are usually slow to start and seldom meet projected timelines. I trust that is the case with both the head-to-head and the canary studies.

Ante